Source: Annual Congress 2006 - Novel research results in genetics and epidemiology of airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. C. van Diemen, D. S. Postma, J. M. Vonk, H. M. Boezen (Groningen, Netherlands). Polymorphisms in surfactant proteins and FEV₁ decline and development of COPD in the general population. Eur Respir J 2006; 28: Suppl. 50, 895

Member's Comments

No comment yet.

Related content which might interest you: Individual decline of FEV1 show diversity in COPD Source: Annual Congress 2012 - Environmental exposure and other risk factors for airway diseases Year: 2012 ADAM33 SNPs are associated with excess FEV1 decline in severe early onset COPD Source: Eur Respir J 2006; 28: Suppl. 50, 582s Year: 2006 The evaluation of different factors that cause FEV1 decline in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 135s Year: 2001 Biomarkers to predict FEV1 decline in smokers and early-onset COPD. Source: Virtual Congress 2020 – Intercellular communication in tissue remodelling of chronic lung diseases Year: 2020 Prediction of respiratory disease mortality in a population sample is improved by expressing lung function impairment as FEV1 quotient Source: Eur Respir J 2005; 26: Suppl. 49, 217s Year: 2005 The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics Source: Eur Respir J 2003; 21: 95-10 Year: 2003 Estimating lung function decline and the effect of smoking in COPD patients Source: Eur Respir J 2002; 20: Suppl. 38, 578s Year: 2002 Which markers other than FEV1 reflect disease progression in COPD? Source: Eur Respir J 2004; 24: Suppl. 48, 45s Year: 2004 Changes in spirometry (FVC and FEV1) in a closed population of COPD patients using new standarized values for Mexican people Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003 Prediction of all cause mortality in a population sample is improved by using FEV1 quotient Source: Annual Congress 2005 - Assessing the relevance of obstructive airway diseases Year: 2005 Improved survival with increased IC/TLC ratio, DLCO and FEV1 in an analysis of a COPD pulmonary function database Source: Annual Congress 2011 - Lung and airway function Year: 2011 Frequent exacerbations in COPD are associated with accelerated rate of FEV1 decline Source: Eur Respir J 2006; 28: Suppl. 50, 32s Year: 2006 Early life origins of adult lung function Source: Annual Congress 2006 - Highlights of epidemiology of COPD and lung function Year: 2006 FEV1 decline in occupational asthma Source: Eur Respir J 2003; 22: Suppl. 45, 488s Year: 2003 The influence of hyperinflation on body composition and cytokine profile in patients with COPD Source: Annual Congress 2013 –Monitoring lung function in airway diseases Year: 2013 Lung function decline in relation to alpha-1-antitrypsin phenotypes in severe asthma Source: Eur Respir J 2003; 22: Suppl. 45, 479s Year: 2003 Evidence for the onset of COPD in childhood, and the role of genetics Source: Annual Congress 2005 - Does COPD begin in childhood? Reviewing the evidence Year: 2005 Rate of FEV1 decline by FEV1 percent predicted in UPLIFT® and TIOSPIR® Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Exacerbation frequency and FEV1 decline of COPD: is it geographic? Source: Eur Respir J 2014; 43: 1220-1222 Year: 2014 Estrogen receptor 1 polymorphisms are associated with bronchial hyperresponsiveness and FEV1 decline, particularly in female asthmatics Source: Eur Respir J 2005; 26: Suppl. 49, 3s Year: 2005